A HSE initiative will result in nearly 35,000 more patients per year getting the blood clot prevention that is appropriate for them, which should lead to substantial reductions in the number of patients developing blood clots. The improvements have been achieved by the 27 Irish hospitals taking part in the Preventing VTE in Hospitals collaborative, led by the HSE Quality Improvement Division.
Multidisciplinary teams from 27 hospitals have attended learning sessions over the past 12 months, building knowledge and skills in quality improvement and in blood clot prevention and engaging with patients, staff and each other to improve care in their hospitals. They have increased the percentage of patients receiving appropriate prevention from a mean of 61% to 79%.
Welcoming the findings, HSE National Director for Quality Improvement, Dr Philip Crowley, said that it is possible to achieve large-scale improvement and the HSE Quality Improvement Division and hospitals are continuing to work to ensure further improvement, sustainability and spread of the initiative.
Clinical lead for the collaborative, Ciara Kirke, says that everybody who is admitted to hospital needs a risk assessment. “Those at risk of blood clots require the appropriate choice, dose and duration of thromboprophylaxis (heparin-like medication, compression stockings or pumps or both to prevent clots) for that particular patient. Patients also need to know about their risk and the symptoms of blood clots, so they can seek urgent medical help if they occur after hospitalisation,” she said.
Last updated on: 14 / 09 / 2017